Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28451525 | 1.00 | SMN1; SMN2 (0.41) | SMN1; SMN2TSHRMAPTFFAR3LCK | |
| Acetic Acid SCHEMBL28514952 | 0.97 | SMN1; SMN2 (0.39) | SMN1; SMN2TSHRMAPTFFAR3LCK | |
| Acetic Acid SCHEMBL28461054 | 0.93 | KDM4E (0.38) | SMN1; SMN2TSHRMAPTFFAR3LCK | |
| Allylamine SCHEMBL27826020 | 0.91 | ALDH1A1 (0.41) | SMN1; SMN2TSHRMAPTFFAR3LCK | |
| Allylamine SCHEMBL4317227 | 0.91 | ALDH1A1 (0.41) | SMN1; SMN2TSHRMAPTFFAR3LCK | |
| Allylamine SCHEMBL21268032 | 0.91 | ALDH1A1 (0.41) | SMN1; SMN2TSHRMAPTFFAR3LCK | |
| Acetic Acid SCHEMBL31425205 | 0.89 | SMN1; SMN2 (0.34) | SMN1; SMN2TSHRMAPTFFAR3LCK | |
| Methacrylic Acid SCHEMBL4704719 | 0.87 | KDM4E (0.38) | SMN1; SMN2TSHRMAPTALDH1A1KMT2A | |
| Acetic Acid SCHEMBL31288509 | 0.87 | SMN1; SMN2 (0.38) | SMN1; SMN2TSHRMAPTALDH1A1KMT2A | |
| Methacrylic Acid SCHEMBL2792667 | 0.85 | KDM4E (0.37) | SMN1; SMN2TSHRMAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115928491-B | Chlorine-free cation dispersed rosin size and preparation method thereof | 上海东升新材料有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-115928491-A | Chlorine-free cation dispersed rosin size and preparation method thereof | 上海东升新材料有限公司 | 2023-04-07 | — | — | CN | claimed |
| EP-2562190-B1 | METHOD FOR PRODUCING DIALLYLAMINE ACETATE POLYMER | NITTO BOSEKI CO LTD (JP) | 2015-09-16 | — | — | EP | claimed |
| CN-102858818-B | Method for producing diallylamine acetate polymer | NITTO BOSEKI CO LTD | 2015-05-06 | — | — | CN | claimed |
| US-8680221-B2 | Method for producing diallylamine acetate polymer | NITTO BOSEKI CO., LTD. (JP) | 2014-03-25 | — | — | US | claimed |
| US-20130079480-A1 | METHOD FOR PRODUCING DIALLYLAMINE ACETATE POLYMER | NITTO BOSEKI CO., LTD. (JP) | 2013-03-28 | — | — | US | claimed |
| EP-2562190-A1 | METHOD FOR PRODUCING DIALLYLAMINE ACETATE POLYMER | Nitto Boseki Co., Ltd (JP) | 2013-02-27 | — | — | EP | claimed |
| CN-102858818-A | Method for producing diallylamine acetate polymer | NITTO BOSEKI CO LTD | 2013-01-02 | — | — | CN | claimed |
| US-4426375-A | DIALLYLAMINE DERIVATIVES | L'OREAL (FR) | 1984-01-17 | — | — | US | claimed |
| US-12637804-B2 | Ink jet recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12630728-B2 | Ink set and recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| EP-3733424-B1 | PRINTING PRETREATMENT SOLUTION, SUBSTRATE FOR PRINTING, AND IMAGE RECORDING METHOD | FUJIFILM CORP (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12584030-B2 | Ink jet ink composition and recording method | SEIKO EPSON CORPORATION (JP) | 2026-03-24 | — | — | US | disclosed |
| US-12576661-B2 | Recording method and recording apparatus | SEIKO EPSON CORPORATION (JP) | 2026-03-17 | — | — | US | disclosed |
| CN-1347811-A | Ink jet recording paper | PRINCE PAPERMAKING CO LTD (JP) | 2002-05-08 | — | — | CN | disclosed |
| US-6361940-B1 | IMMOBILIZATION; GENETIC ENGINEERING | QIAGEN GENOMICS, INC. | 2002-03-26 | — | — | US | disclosed |
| CN-1271400-A | Paper surface treating agent and ink-jet printing paper | HYMO CORP (JP) | 2000-10-25 | — | — | CN | disclosed |
| EP-1022383-A1 | SHEET SURFACE TREATING AGENT AND INK-JET PRINTING PAPER | HYMO CORPORATION (JP) | 2000-07-26 | — | — | EP | disclosed |
| EP-0952228-A2 | Compositions and methods for enhancing hybridization specificity | Rapigene, Inc. (US) | 1999-10-27 | — | — | EP | disclosed |
| US-4426375-A | DIALLYLAMINE DERIVATIVES | L'OREAL (FR) | 1984-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576661-B2 | Recording method and recording apparatus | CA3, CA1, ASIC1 | SMN1; SMN2 503/4885TSHR 3306/4885MAPT 299/4885 |
| US-12630728-B2 | Ink set and recording method | DOT1L, SET, ALKBH3 | SMN1; SMN2 1432/4885TSHR 4820/4885MAPT 569/4885 |
| US-12637804-B2 | Ink jet recording method | IK, PRPH, SLC6A19 | SMN1; SMN2 988/4885TSHR 1740/4885MAPT 44/4885 |
| US-12584030-B2 | Ink jet ink composition and recording method | LSM8, SMURF1, SMAD3 | SMN1; SMN2 29/4885TSHR 3709/4885MAPT 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.